186 related articles for article (PubMed ID: 20332368)
1. Prevalence and management of non-albicans vaginal candidiasis.
Hettiarachchi N; Ashbee HR; Wilson JD
Sex Transm Infect; 2010 Apr; 86(2):99-100. PubMed ID: 20332368
[TBL] [Abstract][Full Text] [Related]
2. Terconazole cream for non-Candida albicans fungal vaginitis: results of a retrospective analysis.
Sood G; Nyirjesy P; Weitz MV; Chatwani A
Infect Dis Obstet Gynecol; 2000; 8(5-6):240-3. PubMed ID: 11220485
[TBL] [Abstract][Full Text] [Related]
3. Treatment of non-albicans Candida vaginitis with amphotericin B vaginal suppositories.
Phillips AJ
Am J Obstet Gynecol; 2005 Jun; 192(6):2009-12; discussion 2012-3. PubMed ID: 15970877
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates.
Lynch ME; Sobel JD
J Med Vet Mycol; 1994; 32(4):267-74. PubMed ID: 7983571
[TBL] [Abstract][Full Text] [Related]
5. Vulvovaginal candidiasis in a Flemish patient population.
De Vos MM; Cuenca-Estrella M; Boekhout T; Theelen B; Matthijs N; Bauters T; Nailis H; Dhont MA; Rodriguez-Tudela JL; Nelis HJ
Clin Microbiol Infect; 2005 Dec; 11(12):1005-11. PubMed ID: 16307555
[TBL] [Abstract][Full Text] [Related]
6. A case series of the management of symptomatic azole-resistant candida.
Challenor R; Pinsent S; Ekanayaka R
Int J STD AIDS; 2012 May; 23(5):375-6. PubMed ID: 22648899
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
[TBL] [Abstract][Full Text] [Related]
8. A 5-year (2000-2004) epidemiological survey of Candida and non-Candida yeast species causing vulvovaginal candidiasis in Graz, Austria.
Paulitsch A; Weger W; Ginter-Hanselmayer G; Marth E; Buzina W
Mycoses; 2006 Nov; 49(6):471-5. PubMed ID: 17022763
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006.
Fan SR; Liu XP; Li JW
J Obstet Gynaecol Res; 2008 Aug; 34(4):561-6. PubMed ID: 18937710
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, susceptibility profile and proteinase production of yeasts causing vulvovaginitis in Turkish women.
Ozcan SK; Budak F; Yucesoy G; Susever S; Willke A
APMIS; 2006 Feb; 114(2):139-45. PubMed ID: 16519751
[TBL] [Abstract][Full Text] [Related]
11. [Prevalence of vaginal candidiasis in pregnant women. Identification of yeasts and susceptibility to antifungal agents].
García Heredia M; García SD; Copolillo EF; Cora Eliseth M; Barata AD; Vay CA; de Torres RA; Tiraboschi N; Famiglietti AM
Rev Argent Microbiol; 2006; 38(1):9-12. PubMed ID: 16784126
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of yeasts implicated in vulvovaginal candidosis in Irish women.
al-Rawi N; Kavanagh K
Br J Biomed Sci; 1999; 56(2):99-104. PubMed ID: 10695049
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, species distribution and antifungal sensitivity of vaginal yeasts in infertile women.
Verghese S; Padmaja P; Asha M; Elizabeth SJ; Anitha A; Kundavi KM; Jayanthi N; Varma T
Indian J Pathol Microbiol; 2001 Jul; 44(3):313-4. PubMed ID: 12024920
[TBL] [Abstract][Full Text] [Related]
14. Boric acid for recurrent vulvovaginal candidiasis: the clinical evidence.
Iavazzo C; Gkegkes ID; Zarkada IM; Falagas ME
J Womens Health (Larchmt); 2011 Aug; 20(8):1245-55. PubMed ID: 21774671
[TBL] [Abstract][Full Text] [Related]
15. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
[TBL] [Abstract][Full Text] [Related]
16. Increased incidence of vulvovaginal candidiasis caused by Candida glabrata in Jordan.
Abu-Elteen KH
Jpn J Infect Dis; 2001 Jun; 54(3):103-7. PubMed ID: 11544399
[TBL] [Abstract][Full Text] [Related]
17. Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists and the German Speaking Mycological Society.
Mendling W; Brasch J; ; ; ;
Mycoses; 2012 Jul; 55 Suppl 3():1-13. PubMed ID: 22519657
[TBL] [Abstract][Full Text] [Related]
18. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
Krcmery V; Barnes AJ
J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Candida glabrata using topical amphotericin B and flucytosine.
Shann S; Wilson J
Sex Transm Infect; 2003 Jun; 79(3):265-6. PubMed ID: 12794227
[No Abstract] [Full Text] [Related]
20. Species spectrum and antifungal susceptibility profile of vaginal isolates of Candida in Kuwait.
Alfouzan W; Dhar R; Ashkanani H; Gupta M; Rachel C; Khan ZU
J Mycol Med; 2015 Mar; 25(1):23-8. PubMed ID: 25534676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
